How to cite item

Outcome of veno-venous extracorporeal membrane oxygenation use in acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass

   
@article{JTD7891,
	author = {Joo Han Song and Won Ki Woo and Seung Hwan Song and Hyo Hyun Kim and Bong Joon Kim and Ha Eun Kim and Do Jung Kim and Jee Won Suh and Yu Rim Shin and Han Ki Park and Seung Hyun Lee and Hyun Chel Joo and Sak Lee and Byung Chul Chang and Kyung Jong Yoo and Young Sam Kim and Young Nam Youn},
	title = {Outcome of veno-venous extracorporeal membrane oxygenation use in acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass},
	journal = {Journal of Thoracic Disease},
	volume = {8},
	number = {7},
	year = {2016},
	keywords = {},
	abstract = {Background: Cardiac surgery with cardiopulmonary bypass (CPB) is a known risk factor for acute respiratory distress syndrome (ARDS). We aimed to analyze the treatment outcome in patients who required veno-venous extracorporeal membrane oxygenation (VV-ECMO) for postcardiotomy ARDS despite other rescue modalities. 
Methods: We retrospectively reviewed the outcomes in 13 patients (mean age, 54.7±5.9 years) who received VV-ECMO support for refractory ARDS after cardiac surgery between March 2013 and February 2016 at Severance Hospital, Yonsei University (Seoul, Korea). 
Results: At the start of VV-ECMO, the average lung injury score was 3.0±0.2, and the Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score was −4±1.1. Although 7 patients initiated VV-ECMO support within 24 h from operation, the remaining 6 started at a median of 8.5 days (range, 5−16 days). Nine (69.3%) patients were successfully weaned from VV-ECMO. After a median follow-up duration of 14.5 months (range, 1.0−33.0 months) for survivors, the 1-year overall survival was 58.6%±14.4%. The differences in the overall survival from VV-ECMO according to the RESP score risk classes were borderline significant (100% in class III, 50%±25% in class IV, and 20%±17.9% in class V; P=0.088). 
Conclusions: VV-ECMO support can be a feasible rescue strategy for adult patients who develop refractory ARDS after a cardiac surgery. Additionally, the RESP score seems a valuable prognostic tool for post-ECMO survival outcome in this patient population as well.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/7891}
}